Tetanus Peptide Melanoma Vaccine

Preferred Label : Tetanus Peptide Melanoma Vaccine;

NCIt definition : A vaccine consisting of peptides derived from melanoma-associated antigens and a modified T-cell epitope derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic and helper T-cell response against tumor cells expressing melanoma-associated antigens, resulting in decreased tumor growth. (NCI04);

Details

Origin ID

C2468;

UMLS CUI

C0677989;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
is_component_of_chemotherapy_regimen
- Montanide ISA-51/Multi-Epitope Melanoma Peptide Vaccine/Sargramostim/Tetanus Peptide Melanoma Vaccine [NCIt concept]
- Montanide ISA-51/Peptide 946 melanoma vaccine/Tetanus peptide melanoma vaccine [NCIt concept]
- Peptide 946 Melanoma Vaccine/QS21/Tetanus Peptide Melanoma Vaccine [NCIt concept]
- gp100 Antigen/Montanide ISA-51/Sargramostim/Tetanus Peptide Melanoma Vaccine/Tyrosinase Peptide [NCIt concept]
- gp100 Antigen/Tetanus Peptide Melanoma Vaccine/Tyrosinase Peptide [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients